Literature DB >> 31028048

Pulmonary-renal syndrome: diagnostic challenge.

Sandra Isabel Correia1, Isabel Eira1, Andre Santa Cruz1, Cristina Ângela1.   

Abstract

Vasculitis presents several diagnostic challenges. Herein, we present a clinical case of a 71- year old woman, observed in our emergency department due to asthenia, vomiting and persistent cough. The patient had a history of progressive renal failure and anaemia over the last years. On physical examinations, fine pulmonary crackles were detected and laboratory test showed haemoglobin 69 g/L, creatinine 4 mg/dL, potassium 6.3 mmol/L, positive antineutrophil cytoplasm antibody (ANCA), with proteins and dimorphic erythrocytes in the urinary sediment. CT analysis of the thorax revealed patchy ground glass haziness, likely due to diffuse alveolar haemorrhage. Pulmonary-renal syndrome was assumed, and induction therapy was initiated. She was discharged after 33 days of hospitalisation. On the following months, ANCA titres remained undetectable, but minor recovery of renal function was observed, requiring haemodialysis. Indeed, the use of aggressive induction therapy at early stage dramatically improve prognosis, maintenance of disease remission may be difficult, as relapse is frequent. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  acute renal failure; lung function; vasculitis

Mesh:

Substances:

Year:  2019        PMID: 31028048      PMCID: PMC6506138          DOI: 10.1136/bcr-2018-227720

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  15 in total

1.  Plasmapheresis with immunosuppressive therapy vs immunosuppressive therapy alone for rapidly progressive anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis.

Authors:  Tsukasa Nakamura; Takaharu Matsuda; Yasuhiro Kawagoe; Yoshihiko Ueda; Isao Ebihara; Hikaru Koide
Journal:  Nephrol Dial Transplant       Date:  2004-07       Impact factor: 5.992

2.  Plasma exchange treatment improves prognosis of antineutrophil cytoplasmic antibody-associated crescentic glomerulonephritis: a case-control study in 26 patients from a single center.

Authors:  Giovanni M Frascà; Maria Letizia Soverini; Alessandra Falaschini; Elena Tampieri; Alba Vangelista; Sergio Stefoni
Journal:  Ther Apher Dial       Date:  2003-12       Impact factor: 1.762

Review 3.  Pulmonary: renal syndrome with a focus on anti-GBM disease.

Authors:  Jan-Stephan F Sanders; Abraham Rutgers; Coen A Stegeman; Cees G M Kallenberg
Journal:  Semin Respir Crit Care Med       Date:  2011-06-14       Impact factor: 3.119

4.  Plasma exchange and immunosuppression in rapidly progressive glomerulonephritis: a controlled, multi-center study.

Authors:  W M Glöckner; H G Sieberth; H E Wichmann; E Backes; R Bambauer; W H Boesken; A Bohle; A Daul; N Graben; F Keller
Journal:  Clin Nephrol       Date:  1988-01       Impact factor: 0.975

Review 5.  Goodpasture's syndrome: a clinical update.

Authors:  Antonio Greco; Maria Ida Rizzo; Armando De Virgilio; Andrea Gallo; Massimo Fusconi; Giulio Pagliuca; Salvatore Martellucci; Rosaria Turchetta; Lucia Longo; Marco De Vincentiis
Journal:  Autoimmun Rev       Date:  2014-11-15       Impact factor: 9.754

6.  A prospective randomized trial of plasma exchange as additive therapy in idiopathic crescentic glomerulonephritis. The Canadian Apheresis Study Group.

Authors:  E Cole; D Cattran; A Magil; C Greenwood; D Churchill; D Sutton; W Clark; P Morrin; G Posen; K Bernstein
Journal:  Am J Kidney Dis       Date:  1992-09       Impact factor: 8.860

7.  Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Negative Small Vessel Vasculitis: A Rare Cause of Pulmonary Renal Syndrome.

Authors:  Boudhayan Das Munshi; Sarbani Sengupta; Abhijeet Sharan; Sarmishtha Mukhopadhyay; Bhaskar Ghosh; Angira Dasgupta; Rana Bhattacharyya
Journal:  Intern Med       Date:  2015-11-01       Impact factor: 1.271

Review 8.  Trojan horses: drug culprits associated with antineutrophil cytoplasmic autoantibody (ANCA) vasculitis.

Authors:  William F Pendergraft; John L Niles
Journal:  Curr Opin Rheumatol       Date:  2014-01       Impact factor: 5.006

9.  EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis.

Authors:  M Yates; R A Watts; I M Bajema; M C Cid; B Crestani; T Hauser; B Hellmich; J U Holle; M Laudien; M A Little; R A Luqmani; A Mahr; P A Merkel; J Mills; J Mooney; M Segelmark; V Tesar; K Westman; A Vaglio; N Yalçındağ; D R Jayne; C Mukhtyar
Journal:  Ann Rheum Dis       Date:  2016-06-23       Impact factor: 27.973

10.  Successful Treatment of Dual-Positive Anti-Myeloperoxidase and Anti-Glomerular Basement Membrane Antibody Vasculitis with Pulmonary-Renal Syndrome.

Authors:  Jinxian Huang; Ling Wu; Xiaoyan Huang; Yan Xie; Jinquan Yu; Jin Yang; Huiqiong Fang; Lijun Zhang
Journal:  Case Rep Nephrol Dial       Date:  2016-01-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.